Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/2005
09/06/2005CA2067690C Amino acid derivatives
09/01/2005WO2005080553A1 Cell-associated physiologically active substance and cell culture supplement
09/01/2005WO2005080549A2 Trioxacarcins and their use against infections
09/01/2005WO2005080419A1 Polypeptide agent for inhibiting sars coronavirus and its derivatives and use thereof
09/01/2005WO2005079860A1 New complexes
09/01/2005WO2005079823A1 Plant-based medicament for the treatment of hepatitis c
09/01/2005WO2004096195A8 Use of ppar-gamma agonists as anti-infective agents
09/01/2005WO2004048512A3 Novel proteins and nucleic acids encoding same
09/01/2005WO2003018759A3 Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same
09/01/2005WO2002083873A3 Enzymes
09/01/2005US20050192332 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same
09/01/2005US20050192328 Compounds and methods for use thereof in the treatment of viral infections
09/01/2005US20050192325 For therapy of bacterial infections; such as N-[((5S)-3-{3-fluoro-4-[exo-(1R,5S)-3-thiabicyclo[3.1.0]hex-6-yl]phenyl}-2-oxo-1,3-oxazolidin-5-yl)methyl]acetamide
09/01/2005US20050192306 Pyrimidine derivatives as selective inhibitors of COX-2
09/01/2005US20050192303 Pyrazolopyridinyl pyridine and pyrimidine therapeutic compounds
09/01/2005US20050192295 6-Chloro-N-cyclopentyl-3-[2-(cyclopentylamino)pyrimidin-4-yl]-2-(3-methylphenyl)pyrazolo[1,5- alpha ]pyridin-7-amine or salt; treatment of a herpes viral infection in human
09/01/2005US20050192275 3-(substituted phenyl)-5-substituted-oxazolidin-2-ones; tuberculosis; e.g. (S)-N-[[3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl]-4-oxo-4-phenylbutanamide
09/01/2005US20050192238 Modulation of the expression of genes dependent on stat-1
09/01/2005US20050192237 Antisense antibacterial cell division composition and method
09/01/2005US20050192236 A substantially crystalline clindamycin free base of three polymorphic/pseudopolymorphic forms; water insoluble so useful for sustained release formulations; storage stability; powder x-ray diffraction; differential scanning calorimetry; bactericides
09/01/2005US20050192235 Compositions and methods for treating or preventing diseases of body passageways
09/01/2005US20050192234 Crystal forms of azithromycin
09/01/2005US20050192232 E.g.,N[(R)-3-dodecanoyloxytetradecanoylamino]-C-aspartic acid, alpha-N-{(4R)-5-hydroxy-4-[(R)-3-hydroxytetradecanoyl- amino]pentyl}amide; grafting antigens to modulate immune response and on a pharmaceutical carrier or antibiotic to enhance therapeutic effect or targetting aqueous conjugate injections
09/01/2005US20050192213 Echinocandin pharmaceutical formulations containing micelle-forming surfactants
09/01/2005US20050191747 Recombinant bovine immunodeficiency virus based gene transfer system
09/01/2005US20050191703 Bioassy for identifying compounds which prevent host proteins interation with viral protein associated with infection, replication, assembly or release; viricides
09/01/2005US20050191696 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products
09/01/2005US20050191695 Documentation means for repertoires of NKR immunoreceptors and/or activatory or non-inhibitory immunoreceptor counterparts of NKR immunoreceptors
09/01/2005US20050191690 Membrane proteins for identifying modulators for prevention and treatment of infection, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders
09/01/2005US20050191649 Identifying mutation in oligoadenylate synthetase gene (OAS1); identifying modulators for prevention and treatment of cell proliferative, nervous system and diabetic disorders
09/01/2005US20050191621 CD4-independent HIV envelope proteins as vaccines and therapeutics
09/01/2005US20050191374 Soluble composition containing sporopollenin and the use thereof
09/01/2005US20050191373 Agent for the prevention and/or treatment of septicemia
09/01/2005US20050191348 Neurodegenerative disease, dementia, affective or mood disorder, drug use and dependence, memory loss disorder, acute neurological traumatic disorder or neurotrauma
09/01/2005US20050191345 Temperature-sensitive liposomal formulation
09/01/2005US20050191334 Sustained release device for implantation in the vitreal chamber or the posterior segment of the eye releasing a corticosteroid for an extended period of time
09/01/2005US20050191316 Neisseria genomic sequences and methods of their use
09/01/2005US20050191301 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses
09/01/2005US20050191300 Immunotherapy of autoimmune disorders using antibodies which target B-cells
09/01/2005US20050191289 Complexes of immunoglobulins and polysaccharides for oral and transmucosal absorption
09/01/2005US20050191275 Method for short-term and long-term drug dosimetry
09/01/2005DE102004004906A1 New oxygen-bridged angucyclinone derivatives, useful for treating bacterial infections and dementia, are modulators of intracellular calcium levels
09/01/2005CA2557333A1 Antifungal peptides
09/01/2005CA2556690A1 New complexes
09/01/2005CA2556425A1 Methods of modulating il-23 activity; related reagents
09/01/2005CA2555236A1 Methods of modulating cytokine activity; related reagents
09/01/2005CA2555235A1 Plant-based medicament for the treatment of hepatitis c
08/2005
08/31/2005EP1568779A1 HSV strains for the oncolytic treatment of cancer
08/31/2005EP1568777A1 Deletion mutants from Neisseria glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
08/31/2005EP1568704A1 Novel 2' ,5' -oligoadenylic acid analogues
08/31/2005EP1568699A1 1,3-dihydroimidazole fused-ring compound
08/31/2005EP1568697A1 1,3-benzothiazinone derivatives, process for producing the same and use thereof
08/31/2005EP1568377A1 Cysteine protease inhibitor
08/31/2005EP1568366A1 Antifungal and/or antimycotic external preparation for nail comprising neticonazole
08/31/2005EP1567640A2 Pokeweed antiviral protein polypeptides with antiviral activity
08/31/2005EP1567532A1 Oxazolidinone and / or isoxazoline derivatives as antibacterial agents
08/31/2005EP1567529A2 Pseudopolymorphic forms of a hiv protease inhibitor
08/31/2005EP1567521A1 Antibacterial compounds
08/31/2005EP1567520A2 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
08/31/2005EP1567506A2 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors
08/31/2005EP1567504A1 Antibacterial agents
08/31/2005EP1567484A1 Polyene polyketides, processes for their production and their use as pharmaceuticals
08/31/2005EP1567181A2 Methods for treatment of helicobacter pylori-associated disorders
08/31/2005EP1567172A2 Formulations useful against hepatitis c virus infections
08/31/2005EP1567154A2 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
08/31/2005EP1567150A1 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics
08/31/2005EP1567137A1 Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections
08/31/2005EP1567117A1 Materials and methods for preventing and treating microbe-mediated epithelial disorders
08/31/2005EP1401407B1 Porous sponge-like cellulosic material for treatment of injuries
08/31/2005EP1397359B1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
08/31/2005EP1390366B1 The citrate salt of 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaene
08/31/2005EP1382608B1 Sulfate of cephem compound
08/31/2005EP1365764B1 Oral pharmaceutical composition of cefpodoxime proxetil
08/31/2005EP1230925B1 Use of a trifluridine derivative alone or combined with a thymidine phosphorylase inhibitor for the treatment of hiv
08/31/2005EP1173475B1 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients
08/31/2005EP1171102B1 Anhydrous tablet of ranitidine hydrochloride with double-layer coating and its composition
08/31/2005EP1095020B1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
08/31/2005EP1078064B1 Compounds from moraxella catarrhalis
08/31/2005EP1003497B1 Il-8 receptor antagonists
08/31/2005EP0996731B1 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses
08/31/2005EP0973819B1 Non-antigenic branched polymer conjugates
08/31/2005EP0941333B1 Immunogenic detoxified mutant e. coli lt-a toxin
08/31/2005EP0786002B1 Intracellular isoform of the interleukin-1 receptor antagonist
08/31/2005EP0721335B1 Mycophenolate mofetil high dose oral suspensions
08/31/2005CN1662540A 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
08/31/2005CN1662530A Azabicyclo-octane and nonane derivatives with DPP-IV inhibiting activity
08/31/2005CN1662514A Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
08/31/2005CN1662508A Compounds, compositions and methods
08/31/2005CN1662505A Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
08/31/2005CN1662251A Adjuvant enhanced immunotherapy
08/31/2005CN1662240A Plymorphic forms of phenyl oxazolidinone derivatives
08/31/2005CN1662236A Inhibitors of histone deacetylase
08/31/2005CN1662226A Monocompartment osmotic controlled drug delivery system
08/31/2005CN1662222A Free-flowing, powdery composition containing alpha-liponic acid (-derivatives)
08/31/2005CN1662177A Appts. and method for shape aesthetics
08/31/2005CN1662152A Nutritious compositions for detoxification and cancer prevention
08/31/2005CN1661373A New target drone of medication for anti hepatitis b virus and application
08/31/2005CN1661036A Method for preparing interferon of white blood cells of dogs
08/31/2005CN1661035A Method for preparing leukocyte interferon of pig
08/31/2005CN1660908A Monoclonal antibody of virus receptor of anti leukoplakia disease and preparation method
1 ... 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 ... 1798